Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing cascara (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
forgiftning med anthraquinonbaseret laksantia |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
1 |
Cascara poisoning |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Accidental cascara poisoning |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Intentional cascara poisoning |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
forgiftning med cascara, uvist med hvilken hensigt |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Anthraquinone laxative adverse reaction (disorder) |
Causative agent |
True |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
1 |
Cascara adverse reaction |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
allergi over for anthraquinonbaseret laksantia |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Allergy to cascara (finding) |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Anthraquinone laxative overdose |
Causative agent |
True |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
1 |
Accidental anthraquinone laxative overdose |
Causative agent |
True |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
1 |
Intentional anthraquinone laxative overdose (disorder) |
Causative agent |
True |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
1 |
overdosis af anthraquinonbaseret laksantia, uvist med hvilken hensigt |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
1 |
Cascara overdose |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Accidental cascara overdose |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Intentional cascara overdose |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
overdosis af cascara, uvist med hvilken hensigt |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
dantron 25 mg/5 ml + poloxamer 200 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
dantron 75 mg/5 ml + poloxamer, stærk 1000 mg/5 ml oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing dantron and poloxamer 188 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
dantron + docusatnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Senna (substance) |
Is a |
True |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing dantron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
anthraquinonbaseret laksantia |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing casanthranol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Frangula 80 microgram/mg and Sterculia gum 620 microgram/mg oral granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing Frangula (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing Frangula and Sterculia gum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Frangula |
Is a |
True |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Cascara (substance) |
Is a |
True |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Dantron |
Is a |
True |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Product containing aloin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
Aloin (substance) |
Is a |
True |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
|
allergi over for anthraquinonbaseret laksantia |
Causative agent |
False |
Anthraquinone laxative (substance) |
Inferred relationship |
Some |
1 |